🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/02/2005 | 37,62 | 37,77 | 36,49 | 37,28 | +0,50% | 3,38% | 1.146.305 |
| 23/02/2005 | 36,19 | 37,62 | 35,82 | 37,09 | +2,59% | 4,96% | 359.740 |
| 22/02/2005 | 36,57 | 37,36 | 35,63 | 36,16 | -2,03% | 4,71% | 364.763 |
| 18/02/2005 | 37,43 | 37,65 | 36,49 | 36,91 | -1,60% | 3,10% | 284.880 |
| 17/02/2005 | 38,07 | 38,67 | 37,13 | 37,50 | -1,96% | 4,03% | 431.634 |
| 16/02/2005 | 38,33 | 39,04 | 37,39 | 38,25 | -0,20% | 4,30% | 580.420 |
| 15/02/2005 | 39,30 | 39,64 | 38,14 | 38,33 | -2,85% | 3,81% | 351.565 |
| 14/02/2005 | 40,80 | 41,36 | 39,38 | 39,45 | -2,41% | 4,86% | 184.532 |
| 11/02/2005 | 39,90 | 41,36 | 39,08 | 40,42 | +1,22% | 5,72% | 340.664 |
| 10/02/2005 | 40,24 | 40,80 | 38,93 | 39,94 | -0,37% | 4,65% | 230.084 |
| 09/02/2005 | 41,85 | 42,11 | 39,30 | 40,09 | -3,77% | 6,71% | 332.649 |
| 08/02/2005 | 42,22 | 42,30 | 41,17 | 41,66 | +0,18% | 2,66% | 274.300 |
| 07/02/2005 | 41,14 | 42,07 | 40,91 | 41,58 | +1,83% | 2,82% | 327.333 |
| 04/02/2005 | 39,56 | 41,06 | 39,45 | 40,84 | +3,41% | 4,07% | 259.259 |
| 03/02/2005 | 40,09 | 40,31 | 38,81 | 39,49 | -0,66% | 3,73% | 220.332 |
| 02/02/2005 | 39,98 | 40,24 | 39,38 | 39,75 | +0,09% | 2,15% | 185.654 |
| 01/02/2005 | 39,15 | 40,57 | 39,11 | 39,71 | +1,92% | 3,73% | 354.904 |
| 31/01/2005 | 39,68 | 40,24 | 38,78 | 38,96 | -0,10% | 3,68% | 387.205 |
| 28/01/2005 | 39,30 | 39,83 | 37,92 | 39,00 | -0,57% | 4,86% | 278.601 |
| 27/01/2005 | 39,00 | 40,05 | 38,44 | 39,23 | +0,67% | 4,13% | 373.659 |
| 26/01/2005 | 38,96 | 39,56 | 38,03 | 38,96 | +0,58% | 3,94% | 298.238 |
| 25/01/2005 | 39,04 | 40,05 | 38,74 | 38,74 | +0,58% | 3,36% | 289.074 |
| 24/01/2005 | 39,86 | 40,16 | 37,73 | 38,52 | -3,38% | 6,10% | 284.399 |
| 21/01/2005 | 40,72 | 40,72 | 39,45 | 39,86 | -0,65% | 3,12% | 280.231 |
| 20/01/2005 | 40,42 | 41,17 | 40,05 | 40,12 | -1,20% | 2,78% | 730.006 |
| 19/01/2005 | 41,21 | 42,48 | 40,09 | 40,61 | -0,09% | 5,81% | 581.248 |
| 18/01/2005 | 39,68 | 41,02 | 39,30 | 40,65 | +2,55% | 4,34% | 635.082 |
| 14/01/2005 | 38,33 | 40,35 | 37,80 | 39,64 | +9,29% | 6,64% | 901.661 |
| 13/01/2005 | 36,27 | 37,39 | 35,11 | 36,27 | +1,36% | 6,30% | 395.166 |
| 12/01/2005 | 37,80 | 37,80 | 35,03 | 35,78 | -3,14% | 7,33% | 390.224 |